Bionyra Pharma Launches With $165M Series A to Advance Inflammatory Disease Treatments

Paris- and Boston-based Bionyra Pharma, has announced the company’s launch with a $165 million oversubscribed Series A funding round co-led... Read More

The post Bionyra Pharma Launches With $165M Series A to Advance Inflammatory Disease Treatments appeared first on citybiz.